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The Toxicity of Inhaled Methyl Isocyanate in
F344/N Rats and B6C3F1 Mice. II. Repeated
Exposure and Recovery Studies
by John R. Bucher,* Bhola N. Gupta,* Morrow Thompson,*
Bernard Adkins, Jr.,t and Bernard A. Schwetzt
F344/N rats and B6C3F1 mice were exposed to 0, 1, 3, or 6 ppm methyl isocyanate by inhalation for 6
hr on 4 consecutive days. Deaths of rats were observed following 3 ppm exposures, and mice died after
exposures to 6 ppm. Deaths appeared to be related to severe respiratory distress. Survivors in high dose
groups lost weight initially, then gained weight at rates equal to controls throughout a 91-day recovery
period. Lung weights increased significantly in male and female rats exposed to 3 ppm, but no persistent
changes in brain, kidney, thymus, spleen, liver, or testis weights were seen in either mice or rats.
Blood and serum from male and female rats were taken for clinical pathology and hematology assess-
ments on day 7 of postexposure, the day prior to the first observed deaths of these animals. No changes
or only slight changes were seen in measures ofserum alanine aminotransferase, sorbitol dehydrogenase,
alkaline phosphatase, or in blood and brain cholinesterase activities. However, serum creatine kinase
increased with dose in both males and females. Blood urea nitrogen, creatinine, and methemoglobin were
unchanged. Nochangeswereseenincountsofredbloodcellsorplatelets, orinredcellindicies. Hemoglobin
concentrations and hematocrits were slightly elevated. No changes were noted in absolute leukocyte
counts, but counts of segmented neutrophils increased and lymphocytes decreased. These changes are
consistentwithslighthemoconcentration andastress-relatedleukogram, as seeninacuteexposurestudies.
These studies provide toxicity information for further NIEHS studies of immunotoxicity, reproductive
toxicity, and genetic toxicity using this repeated exposure regimen, which are also reported in this issue.
Theresults indicate thattherespiratory system isthe primary site ofinjuryfollowingrepeatedinhalations
of lethal and sublethal concentrations of methyl isocyanate, and give little evidence of direct effects on
nonrespiratory tissues.
Introduction
The previous paper in this series outlined changes in
F344 rats and B6C3F1 mice following a single 2-hr in-
halation exposure to lethal and sublethal concentrations
of methyl isocyanate (1). This exposure pattern was
chosen to mimic in duration and result the December
3, 1984, release of methyl isocyanate from a storage
tank at an agricultural chemical plant in Bhopal, India.
The results of this study (1-3) demonstrated that the
lung and upper respiratory tract were the primary tar-
gets of methyl isocyanate injury and suggested that
damage to the respiratory tract was severe enough to
account for the observed mortality. Results ofthe pre-
vious study also demonstrated a very steep dose re-
sponse for lethality of inhaled methyl isocyanate, with
concentrations of 10 ppm causing few or no deaths in
*The National Toxicology Program, National Institute ofEnviron-
mental Health Sciences, P. 0. Box 12233, Research Triangle Park,
NC 27709.
tNorthrop Services Inc., P. 0. Box 12313, Research Triangle Park,
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rats or mice, but concentrations of20 to 30 ppm being
lethal to 60 to 80% ofexposed animals.
Because of the overwhelming pulmonary injury and
events secondary to this injury that occur during short
exposures to high concentrations ofmethyl isocyanate,
it is possible that direct injury to other organs or organ
systems could be obscured using this type ofexposure
regimen. For this reason we have performed studies
whichhaveexamined varioustoxicendpointsinanimals
exposed repeatedly to lower concentrations of methyl
isocyanatebyinhalation. Inthesestudies, ratsandmice
ofboth sexes were exposed to 0, 1, 3, or in one case, 6
ppm methyl isocyanate for 6 hr on 4 consecutive days.
Animals were taken for histopathologic evaluation on
postexposure days 7, 28, 49, and 91. Blood was taken
from rats for clinical pathology and hematology studies
on day 7, and body weights were collected periodically
throughout the 3-month postexposure period. This ex-
posureregimenisthesameasthatusedinotherNIEHS
studies of immunotixicity and myelotoxicity in female
mice (4,5), andreproductive andgenetictoxicityinmale
and female mice (6,7). This report contains data con-BUCHER ETAL.
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FIGURE 1. Survival of rats following four, 6-hr exposures to 3 ppm
MIC, N = 30. Actual concentrations were: malerats, 2.98 + 0.21;
female rats, 2.79 ± 0.41 ppm. Exposures occurred during days
1-4 (ex).
cerning animal mortality, body and organ weights, and
results of clinical pathology and hematology studies.
Histopathology findings have notyetbeenfinalized, and
therefore will be reported elsewhere.
Materials and Methods
Methyl isocyanate (> 99% pure) was supplied by
Union Carbide Corp. Male and female F344/N rats and
B6C3F1 mice (4-6 weeks old) were obtained from
Charles River(Kingston NY, orPortage, MI) and were
quarantined for 10 to 21 days prior to random distri-
bution to exposure groups. Exposures were carried out
in 1,330 L, stainless-steel exposure chambers. Details
ofvapor generation, monitoring and safety aspects are
reported by Adkins et al. (8). Exposures were con-
ducted on 6-17 to 6-20, and 6-25 to 6-28-85. Procedures
used, details of animal housing, feed and water, and
viral serology and sentinel animal program have been
outlined (1). Rats used were found negative for anti-
bodies toRCV/SDA, Sendai, KRV, PVM and H-1. Mice
were negative for MHV, Sendai, PVM, GDVII and
EDIM.
Rats and mice were exposed to concentrations of 0,
1, or 3 ppm MIC for 6 hr on 4 consecutive days. One
group ofmale rats was exposed to 3 ppm for 6 hr on 1
day only, and one group of male and female mice was
exposed to 6 ppm, 6 hr per day, for 4 days in range
finding studies. On postexposure days 7, 28, 49, and 91,
five predesignated animals per group were killed by
pentobarbital overdose and subjected to a complete
grossnecropsy. Thelungs, brain, liver, kidney, thymus,
testis, and spleen were weighed prior to fixation for
histopathologic examination. Immediately prior to ne-
cropsy, blood was obtained from the right cardiac ven-
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FIGURE 2. Survival ofmice following four, 6-hr exposures to 6 ppm
MIC, N = 20. Actual exposure concentrations were 5.83 ± 1.05
ppm. Exposures occurred during days 1-4 (ex). The experiment
was terminated on day 19.
tricle of anesthetized rats on day 7 of postexposure.
Each sample was divided, and one fraction was allowed
to clotforserum collection; the otherfractionwasadded
to a tube containing a premeasured amount of ETDA.
Serum samples were analyzed for activities of alanine
aminotransferase (9), alkaline phosphatase (10), crea-
tine kinase (11), sorbitol dehydrogenase (12), and con-
centrations of urea nitrogen (13), and creatinine (14).
Samples of whole blood were used for determinations
oftotal blood cell counts (laseroptics counter), forprep-
aration ofblood smears (morphologic evaluationand dif-
ferential counts), and for measurements of concentra-
tions of methemoglobin (15) and activities of
cholinesterase (16). Cholinesterase activitywas also de-
terminedinhomogenatesofbraintissue. Fortheseanal-
yses, the right hemisphere was taken, chilled, and ho-
mogenized in 10 volumes of 0.25 M sucrose. Animals
werecheckedformortality, morbidity, andclinicalsigns
twice daily throughout the first month, and once daily
thereafter.
Statistical Methods
Statistical analyses were performed using the RS/1
Multicompare procedure, theWilk-Shapiro testfornor-
mality, and the pooled variance t test for differences in
body and organ weights, clinical pathology, and hem-
atology. Data expressed in the form ofratios were ana-
lyzed using the Wilcoxon rank sum test.
Results
Clinical Signs and Mortality
Signsofanimaldiscomfortweregenerallylessintense
during the repeated exposures than during single ex-
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posures to higher concentrations of MIC (1). No nasal
or oral discharge was noted during the exposures, but
animals exposed to 3 or 6 ppm appeared stressed upon
removal fromthe chambers. Animals were inactive and
often had a ruffled haircoat. Rats showed signs of eye
irritation and blinking. Signs were most severe after
first exposure and lessened during subsequent expo-
sures. Signs ofdyspnea were observed in rats exposed
to 3 ppm and in mice at 6 ppm at various times during
the four exposures (rats were not exposed to 6 ppm in
thesestudies), butbreathingwaslessaffectedornormal
by the start ofthe next exposure day.
During the first week following the exposures, rats
exposed to 3 ppm and mice exposed to 6 ppm showed
signs of labored breathing and ruffled haircoat. The
signs were similar to those exhibited by animals in the
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higher dose groups in the single dose studies (1) and
worsened with time. Three of20 male mice died during
the third and fourth days of exposure to 6 ppm, but
most deaths of high dose (3 ppm) rats and high dose
mice (6 ppm) began 8 days after the last exposure and
continued for several weeks (Figs. 1, 2). These doses
killed nearly 100% ofmale rats, male mice, and female
rats, but female mice appeared less affected than the
other groups, which is consistent with the findings of
the single dose studies (1). No male or female rats ex-
posed to 1 ppm, or female mice exposed to 1 or 3 ppm,
died during the 91-day follow-up studies; mortality of
male mice in 3 ppm was 1/30 in one study, and 1/20 in
a second study. No male mice died following exposure
to 1 ppm. Severely affected animals rarely ate or drank
during periods of respiratory distress. While deaths
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FIGURE 3. Mean body weights for (A) male rats, (B) female rats, (C) male mice, and (D) female mice, following exposures to 0, 1, or 3 ppm
MIC during days 1-4. N began as 20 and decreased by 5 on each postexposure analysis day (7, 28, 49 and 91). Because of deaths, N
decreased more rapidly for high dose male and female rats. Average chamber concentrations were as follows: male rats and mice, 1.13 ±
0.16, 2.98 + 0.21; female rats and mice, 1.13 + 0.23, 2.79 ± 0.41 (A, p < 0.05).
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were clearly due primarily to respiratory embarrass-
ment, dehydration may have also been a factor.
Body and Organ Weights
Effects on body weights were dose-related in all ex-
posure groups (Fig. 3). Both male and female mice
showed an initial weight loss immediately following the
exposures to 3 ppm, but weight gain then resumed and
achieved rates equal to controls. Both male and female
rats showed significant decreases in body weight fol-
lowingthe exposures to3ppm, andbothgroupsshowed
a transient gain in weight just prior to the onset of
worsening respiratory problems. All high dose female
rats diedbeforethepostexposure day-28scheduled sac-
rifice, and the last two surviving male rats in the high
dose group were killed on day 28.
Significant changes inlungweights were seeninmale
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and female rats and in male mice following exposure to
3 ppm MIC (Fig. 4). On days 7 and 28 ofpostexposure,
boththe absolute lungweights andlung-to-bodyweight
ratios (not shown) of3ppmmale rats were significantly
greater than in controls. Interestingly, lung weights
were even higher in the group ofmale rats which had
been exposed to 3 ppm, 6 hr, for only 1 day (Fig. 4A).
This group had a body weight that averaged 125 g vs.
the control weight of 180 g, 7 days postexposure. Male
mice also had a significantly elevated lung-to-bodyratio
on day 7 postexposure, and absolute lungweights were
greaterthancontrolsonday91. Nosignificantincreases
in lung weight were seen in female mice. Exposure-
related changes in lung weights were much less dra-
matic in mice than in rats during the 91-day postex-
posure period. However, the severe early changes in
rats are consistent with the deaths observed in these
groups. The lungs ofmicewere apparentlyless affected
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FIGURE 4. Lung weights of(A) male rats, (B) female rats, (C) male mice, (D) female mice, following exposures to 0, 1, or 3 ppm for 4 days.
The group ofmale rats indicated by (0) was exposed to 3 ppm for one 6-hrperiod only. N = 5 for each point, except for 3 ppm male rats,
day 28, where N = 2 (A, p < 0.05). Exposures occurred during days 1-4.
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by 3 ppm MIC, and consequently mortality was much
lower in mice than in rats at 3 ppm.
Thymus-to-body andliver-to-bodyweightratios were
lower (9 to 16%) in high dose male and female rats than
incontrols onday 7postexposure (notshown); excessive
mortality prevented analysis of this group later in the
study. Spleen-, kidney-, brain- and testis-to-body
weight ratios were either unchanged or slightly higher
than controls indosed rats throughout the studies. This
may suggest a selective effect on the liver and thymus,
but all of these marginal changes are consistent and
expected, considering the decrease in body weight and
the apparent poor nutritional status of the high dose
animals. In mice, absolute thymus weights were lower
inhigh dose (3 ppm) females onday 7 postexposure, but
no consistent changes in other organ-to-body weight
ratios were seen in any dose group at any time during
the study.
Clinical Pathology and Hematology
Sera, blood, andbraintissue wereanalyzed frommale
and female rats on day 7 postexposure only. This was
the day preceding the onset of deaths ofhigh dose an-
imals. No change or only slight changes in serum activ-
ities ofalanine aminotransferase, alkaline phosphatase,
andsorbitoldehydrogenase wereobservedindosed ver-
sus control rats, but serum creatine kinase activity was
significantly increased inboth lowand high dose groups
ofmale and female rats (Table 1). Blood urea nitrogen,
creatinine and methemoglobin concentrations, and
blood and brain cholinesterase activities were un-
changed in dosed rats. There were no changes in counts
ofredblood cells orplatelets, orinred cellindices (mean
corpuscular volume, mean corpuscular hemoglobin,
meancorpuscularhemoglobinconcentration). Hemoglo-
bin concentrations and hematocrits were mildly in-
creased (< 10%) in high dose male and female rats.
Although there were no significant changes in total leu-
kocyte counts, dose-related trends did occur inabsolute
counts of segmented neutrophils (increased) and lym-
phocytes (decreased) (Table 2). No changes were noted
in absolute counts of other cell types (immature neu-
trophils, monocytes, eosinophils or basophils).
Discussion
In single dose studies, exposure to MIC at 3 ppm for
2hrresulted inminimalinflammation inthenasal cavity
ofrats and mice, and no effects on other indices oftox-
Table 1. Rat serum creatine kinase activity
on postexposure day 7.
Creatine kinase activity, U/L
Exposure group, ppm Males Females
0 280.4 ± 11.8 235.2 ± 26.8
1 467.8 ± 41.9W 425.7 ± 32.7a
3 445.8 ± 25.la 604.0 ± 36.8a
Table 2. Total and differential leukocyte counts in rats.a
Exposure Segmented
Sex group, ppm Total neutrophils Lymphocytes
Male 0 4.06 0.97 2.93
(0.63) (0.20) (0.53)
1 3.62 1.00 2.45
(0.26) (0.16) (0.28)
3 3.78 1.28 2.34
(0.52) (0.27) (0.40)
Female 0 3.14 0.78 2.25
(0.49) (0.24) (0.32)
1 3.00 0.85 1.98
(0.50) (0.28) (0.29)
3 3.08 0.97 1.90
(0.80) (0.42) (0.49)
aData are means (SD), 1000/,uL, N= 5, counts from one outlier
omitted from male 3 ppm group.
icity (1,2). However, the results of the present study
clearly indicate continued exposure to this concentra-
tion results in severe injury and death. The sensitivity
ofthe various groups to methylisocyanate toxicity was
similar to that observed in the previous study (1), with
lethal doses for rats approximately one half those for
mice. Femalemiceappearedlessaffectedthananyother
group. Male rats exposed for one, 6-hr period to 3 ppm
had more respiratory signs following the exposure than
did male rats exposed to 3 ppm on 4 consecutive days.
All five male rats exposed to 3 ppm for 1 day only were
killed on postexposure day 7, so it is not known ifthis
exposure is lethal; however, lung weights and lung-to-
body weight ratios were higher than those seen in the
group exposed for four, 6-hr periods. High mortality
hasbeenobservedinallMIC-exposedanimalsthathave
shownelevatedlungweights, andthedegreeofincrease
in lung weight subjectively correlates with the extent
of obstructive, fibroproliferative lung changes and the
retentionoffluidandmucus(3). Thehigherlungweights
seen at 7 days ofpostexposure in male rats exposed for
one 6-hr period to 3 ppm than in male rats exposed for
4daysto3ppmsuggeststhatfibroproliferative changes
may have occurred more rapidly in the lungs of rats
exposed for only one 6-hr period to 3 ppm. Preliminary
histopathology results support this interpretation.
Exposure to 1 ppm was without apparent effect on
the lung or other organs in any group of rats or mice,
suggesting that at this concentration, sufficient MIC
may not have reached critical regions ofthe bronchi or
bronchioles. MIC may not have reached criticalregions
if complete scavenging of the highly reactive material
(17) occurred at higher levels of the respiratory tract.
This explanation remains to be confirmed by electron
microscopy studies.
Clinical pathology and hematology studies similar to
those performed here were conducted on male and fe-
male rats immediately after exposure and at various
timesfollowingsingleexposurestoMIC (1). Allchanges
were considered secondary to effects ofrespiratory in-
jury and to hemoconcentration in dehydrated animals.
In the present study, measurements were taken on the
day preceding the onset ofdeaths ofrats in the 3 ppm
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group. Slight effects of hemoconcentration were again
noted in hematologic assessments, and no signs ofspe-
cific liver or kidney damage were noted in measures of
serum alanine aminotransferase, alkaline phosphatase,
sorbitol dehydrogenase, and in blood BUN and creati-
nine. Blood and brain cholinesterase were not affected.
The mild changes in absolute counts ofsegmented neu-
trophils (increased) and lymphocytes (decreased) were
consistent with a stress leukogram, and were similarto
changes seen following acute exposures (1). Activities
of creatine kinase in serum were increased in animals
inboththe 1 and3ppmtreatmentgroups. Theincreases
were mild (approximately 2- to 3-fold) and were not
considered to be asignificant treatment-related finding.
In tissues, creatine kinase activity is high in brain and
skeletal and cardiac muscles. High serum activities are
generally produced by diseases of or damage to mus-
culartissue. WhileadirecteffectofMICorametabolilte
on cardiac or skeletal muscle cannot be ruled out, in-
creases ofthis magnitude and greater can be produced
by physical exercise or exertion, trauma, or muscular
cramps. The high dose rats were clearly suffering from
respiratory distress. Low dose animals were not, but
changes in creatine kinase activity ofthis magnitude do
not suggest that primary muscular injury was a signif-
icant component ofmethyl isocyanate toxicity.
The intent behind the four exposure experimental
design was to maximize our ability to detect evidence
of direct toxicity of methyl isocyanate to extrapulmo-
nary organs or organ systems. Exposure of rats to 3
ppm and mice to 6 ppm for 4 days resulted in deaths
commencing approximately 1 week after the last ex-
posure. All evidence derived from these studies sug-
gests deaths were caused by respiratory compromise,
and little evidence for direct, significant extrapulmon-
ary injury was found in measures oforgan weights and
clinical pathology and hematology in animals exposed
repeatedly to lethal or sublethal concentrations of
methyl isocyanate by inhalation.
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